- cafead   Jun 27, 2023 at 10:32: AM
via The FDA approved Pfizer Inc's (NYSE: PFE) Litfulo (ritlecitinib), an oral treatment for severe alopecia areata in individuals 12 and older.
Litfulo is the first and only FDA-approved treatment for adolescents (12+) with severe alopecia areata.
article source
Litfulo is the first and only FDA-approved treatment for adolescents (12+) with severe alopecia areata.
article source